Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Muge Serhatli"'
Autor:
Öznur Karaoğlu, Müge Serhatlı, Ebru Pelvan, Bülent Karadeniz, Ilknur Demirtas, Gamze Çakırca, Hande Sipahi, Yağmur Özhan, Gözdem Karapınar, Mohammad Charehsaz, Ahmet Aydın, Erdem Yesilada, Cesarettin Alasalvar
Publikováno v:
Journal of Functional Foods, Vol 105, Iss , Pp 105544- (2023)
Prevention of COVID-19 is of paramount importance for public health. Some natural extracts might have the potential to suppress COVID-19 infection. Therefore, this study aimed to design a standardised, efficient, and safe chewable tablet formulation
Externí odkaz:
https://doaj.org/article/f14f412ead4744c49d140cb5e4207939
Autor:
Neslihan Pakize Taşlı, Zeynep Burçin Gönen, Oğuz Kaan Kırbaş, Nur Seda Gökdemir, Batuhan Turhan Bozkurt, Buse Bayrakcı, Derya Sağraç, Ezgi Taşkan, Sevda Demir, Nur Ekimci Gürcan, Melike Bayındır Bilgiç, Ömer Faruk Bayrak, Hazel Yetişkin, Büşra Kaplan, Shaikh Terkıs Islam Pavel, Gökçen Dinç, Müge Serhatlı, Gamze Çakırca, Ahmet Eken, Vedat Aslan, Mehmet Yay, Musa Karakukcu, Ekrem Unal, Fethi Gül, Kemal Erdem Basaran, Yusuf Ozkul, Fikrettin Şahin, Olcay Y. Jones, Şaban Tekin, Aykut Özdarendeli, Mustafa Cetin
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The scale of the COVID-19 pandemic forced urgent measures for the development of new therapeutics. One of these strategies is the use of convalescent plasma (CP) as a conventional source for passive immunity. Recently, there has been interest in CP-d
Externí odkaz:
https://doaj.org/article/29030acd84a84397aaf33a65520ad6ba
Autor:
Ayca Yildiz Pekoz, Ozlem Akbal Dagistan, Hanan Fael, Meltem Culha, Aybige Erturk, Nur Sena Basarir, Gokben Sahin, Muge Serhatli, Gamze Cakirca, Saban Tekin, Leyla Semiha Sen, Mustafa Sevim, Lutfiye Mulazimoglu Durmusoglu, Berrak C. Yegen
Publikováno v:
Drug Delivery, Vol 29, Iss 1, Pp 2846-2854 (2022)
Favipiravir, an RNA-dependent RNA polymerase (RdRp) inhibitor, is used to treat patients infected with influenza virus and most recently with SARS-CoV-2. However, poor accumulation of favipiravir in lung tissue following oral administration has requi
Externí odkaz:
https://doaj.org/article/bdfea95241b44c239c118b5475ad3aa0
Autor:
Şeyma Işık, Aylin Ozdemir Bahadir, Beytullah Özgür, Melis Denizci Öncü, Gizem Dinler Doganay, Bertan Koray Balcioglu, Hasan Umit Ozturk, Muge Serhatli, Berrin Erdağ
Publikováno v:
Biotechnology and Applied Biochemistry. 69:2122-2137
Development of monoclonal antibody therapeutics against vascular endothelial growth factor receptor 2 (VEGFR-2) protein, which is the main regulator in angiogenesis, has been a major challenge for years. In the current study, we engineer an inclusion
Autor:
Muge Serhatli, Filiz Kaya, Aylin Ozdemir Bahadir, Fatima Yucel, Şaban Tekin, Hivda Polat, Melis Denizci Öncü, Bertan Koray Balcioğlu, Hasan Umit Ozturk
Publikováno v:
Turkish Journal of Biology
Volume: 44, Issue: SI-1 203-214
Volume: 44, Issue: SI-1 203-214
In December 2019 a novel coronavirus was detected in Wuhan City of Hubei Province-China. Owing to a high rate of transmission from human to human, the new virus called SARS-CoV-2 differed from others by its unexpectedly rapid spread. The World Health
Autor:
Ece Erdemoglu, Nurettin Tokay, Şaban Tekin, Lalehan Oktay, Elif Acar, Hasan DeMirci, Timucin Avsar, Alpsu Olkan, Yesim Yumak, Bertan Koray Balcioglu, Muge Didem Orhan, Seyma Calis, Hasan Umit Ozturk, Sehriban Buyukkilic, Yuksel Cetin, Yasar Enes Butun, Aysenur Ozcan, Atilla Akdemir, Muge Serhatli, Şeyma Işık, Tugba Bagci-Onder, Seyma Aydinlik, Mustafa Guzel, Serdar Durdagi, Alisan Kayabolen, Ilayda Tolu
Publikováno v:
Molecular Therapy
Small molecule inhibitors have previously been investigated in different studies as possible therapeutics in the treatment of SARS-CoV-2. In the current drug repurposing study, we identified the leukotriene (D4) receptor antagonist Montelukast as a n
Autor:
Emel Akgun, Betul Sahin, Mete Bora Tuzuner, Zelal Adiguzel, Muge Serhatli, Cigdem Acioglu, Busra Gurel, Ahmet Tarik Baykal, Ceyda Acilan
Publikováno v:
Current Proteomics. 16:136-147
Background and Objective: Antimycin A (AntA) is a potent Electron Transport System (ETS) inhibitor exerting its effect through inhibiting the transfer of the electrons by binding to the quinone reduction site of the cytochrome bc1 complex (Complex II
Autor:
Yesim Yumak, Ece Erdemoglu, Elif Acar, Aysenur Ozcan, Ilayda Tolu, Muge Didem Orhan, Yuksel Cetin, Alisan Kayabolen, Alpsu Olkan, Şaban Tekin, Şeyma Işık, Hasan DeMirci, Timucin Avsar, Sehriban Buyukkilic, Muge Serhatli, Tugba Bagci-Onder, Bertan Koray Balcioglu, Nurettin Tokay, Yasar Enes Butun, Serdar Durdagi, Atilla Akdemir, Lalehan Oktay, Seyma Calis, Hasan Umit Ozturk, Seyma Aydinlik, Mustafa Guzel
Small molecule inhibitors have previously been investigated in different studies as possible therapeutics in the treatment of SARS-CoV-2. In the current drug repurposing study, we identified the leukotriene (D4) receptor antagonist Montelukast as a n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8788d857d84e850cdf2d2aa14fde6598
https://doi.org/10.1101/2020.12.26.424423
https://doi.org/10.1101/2020.12.26.424423
Autor:
Melis Denizci Öncü, Filiz Kaya, Hasan Umit Ozturk, Aylin Özdemirbahadir, Nurşah Ersezen, Hilal Yazici, Berrin Erdağ, Bertan Koray Balcioğlu, Muge Serhatli
Publikováno v:
AYDIN TIP FAKÜLTESİ KLİNİKLERİ DERGİSİ. 3:115-125
Autor:
Seyma Isik, Ozcesmeci, Mukaddes, Burat, Ayfer Kalkan, Hamuryudan, Esin, Adiguzel, Zelal, Oncü, Melis Denizci, Bertan Koray Balcioglu, Bahadir, Aylin Ozdemir, Özturk, Hasan Ümit, Kaya, Filiz, Erdag, Berrin, Ozge Can, Muge Serhatli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::173bc2e2bbc3670751941a87e88af417